MIC
ABBV icon

Mubadala Investment Company’s AbbVie ABBV Stock Holding History

Mubadala Investment Company’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.05M Buy
20,084
+282
+1% +$60.7K 0.01% 37
2026
Q1 		$4.31M Buy
19,802
+2,804
+16% +$622K 0.02% 34
2025
Q4 		$3.88M Buy
+16,998
New +$3.87M 0.02% 38
2025
Q3 		– Sell
-18,664
Closed -$3.46M – 59
2025
Q2 		$3.46M Sell
18,664
-3,184
-15% -$592K 0.02% 32
2025
Q1 		$4.58M Buy
21,848
+2,063
+10% +$401K 0.03% 10
2024
Q4 		$3.52M Buy
+19,785
New +$3.64M 0.02% 28

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Mubadala Investment Company's ABBV Position: Q2 2026 in Review

Mubadala Investment Company increased its AbbVie (ABBV) stake by 1.4% in Q2 2026, buying an estimated $60.7K and bringing the position to 20,084 shares worth $5.05M. The position accounts for 0.01% of the portfolio, ranked #37.

Mubadala Investment Company first reported a position in ABBV in Q4 2024 and has held it in 6 quarters since. 4,232 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Mubadala Investment Company held 20,084 shares of AbbVie worth $5.05M as of Q2 2026.
  • Mubadala Investment Company bought 282 AbbVie shares in Q2 2026, an estimated $60.7K.
  • AbbVie made up 0.01% of Mubadala Investment Company's portfolio in Q2 2026, its #37 holding.
  • Mubadala Investment Company first reported a position in AbbVie in Q4 2024 and has held it in 6 quarters since.
  • 4,232 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Mubadala Investment Company's 13F filing for Q2 2026, filed 14 Aug 2026.